[1]Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome[J]. N Engl J Med,2009,360:1226-1237. [2]姚紫云,姚飞荣,李文娟,等. 烟雾病的研究进展[J]. 中国血液流变学杂志,2021,31:137-141. [3]Berry JA, Cortez V, Toor H, et al. Moyamoya: an update and review[J]. Cureus,2020;12: e10994. doi:10.7759/cureus.10994. [4]Shang S, Zhou D, Ya J, et al. Progress in moyamoya disease[J]. Neurosurg Rev,2020,43:371-382. [5]He S, Duan R, Liu Z, et al. Characteristics of cognitive impairment in adult asymptomatic moyamoya disease[J]. BMC Neurol,2020,20: 322. doi: 10.1186/s12883-020-01898-8. [6]Fujimura M, Tominaga T, Kuroda S, et al.2021 Japanese Guidelines for the management of moyamoya disease: guidelines from the research committee on moyamoya disease and Japan stroke society[J]. Neurol Med Chir (Tokyo),2022,62:165-170. [7]Tasbihgou SR, Absalom AR. Postoperative neurocognitive disorders[J]. Korean J Anesthesiol,2021,74:15-22. [8]He S,Liu Z, Wei Y, et al. Impairments in brain perfusion,executive control network, topological characteristics, and neurocognition in adult patients with asymptomatic moyamoya disease[J]. BMC Neurosci,2021,22:35. doi: 10.1186/s12868-021-00638-z. [9]Sun J, Shi Z, Yu L, et al. Predictors of preoperative cognitive dysfunction in adults with Moyamoya disease: a preliminary research[J]. BMC Neurol,2022,22:12. doi: 10.1186/s12883-021-02511-2. [10]Liu Z, He S, Wei Y, et al. Changes of cerebral cortical structure and cognitive dysfunction in “healthy hemis-phere” after stroke: a study about cortical complexity and sulcus patterns in bilateral ischemic adult moyamoya disease[J]. BMC Neurosci,2021,22:66. doi: 10.1186/s12868-021-00672-x. [11]Deckers PT, Kronenburg A, van den Berg E, et al. Clinical outcome, cognition, and cerebrovascular reactivity after surgical treatment for moyamoya vasculopathy: a dutch prospective, single-center cohort study[J]. J Clin Med,2022,11: 7427-7450. [12]Festa JR, Schwarz LR, Pliskin N, et al. Neurocognitive dysfunction in adult moyamoya disease[J]. J Neurol,2010,257:806-815. [13]Karzmark P, Zeifert PD, Tan S, et al. Effect of moya-moya disease on neuropsychological functioning in adults[J]. Neurosurgery,2008,62:1048-1052. [14]Shi Z, Wen YJ, Huang Z, et al. Different aspects of cognitive function in adult patients with moyamoya disease and its clinical subtypes[J]. Stroke Vasc Neurol,2020,5:86-96. [15]Ogasawara K, Uchida S, Akamatsu Y, et al. Outcomes of medical management alone for adult patients with cerebral misery perfusion due to ischemic moyamoya disease[J]. J Stroke Cerebrovasc Dis,2022,31:106588.doi:10.1016/j.jscrokecerebrovasalis.2022.106558. [16]Lei Y, Li YJ, Guo QH, et al. Postoperative executive function in adult moyamoya disease: a preliminary study of its functional anatomy and behavioral correlates[J]. J Neurosurg,2017,126:527-536. [17]Zeifert PD, Karzmark P, Bell-Stephens TE, et al. Neurocognitive performance after cerebral revascularization in adult moyamoya disease[J]. Stroke,2017,48:1514-1517. [18]Bao Y, Yu F, Wei L, et al. Association between cognitive decline and altered cerebral perfusion in adults with moyamoya disease after revascularization[J]. Cerebrovasc Dis,2022,51:764-773. [19]Venkatraghavan L, Poublanc J, Bharadwaj S, et al. Noninvasive measurement of cerebral blood flow under anesthesia using arterial spin labeling MRI: a pilot study[J].J Neurosurg Anesthesiol,2016,28:331-336. [20]Lang SS, Vollmer E, Wu L, et al. A retrospective study of neurological complications in pediatric patients with moyamoya disease undergoing general anesthesia[J]. Anesth Analg,2021,132:493-499. [21]黄祥,韩明明,殷国兵,等.目标导向液体治疗对缺血型烟雾病患者脑血管重建术后谵妄的影响[J].临床麻醉学杂志,2020,36:13-16. [22]Noshiro S, Mikami T, Komatsu K, et al. Neuromo-dulatory role of revascularization surgery in moyamoya disease[J]. World Neurosurg,2016,91:473-482. [23]Lu J, Xia Q, Yang T, et al. Electroencephalographic features in pediatric patients with moyamoya disease in China[J]. Chin Neurosurg J,2020,6:3.doi:10.1186/s41016-019-0179-2. [24]Calviere L, Catalaa I, Marlats F, et al. Correlation between cognitive impairment and cerebral hemodynamic disturbances on perfusion magnetic resonance imaging in European adults with moyamoya disease: clinical article[J]. J Neurosurg,2010,113:753-759. |